Kangmei Pharma | 600518 - Vermögenswerte

Aktienkurs
1.71
Täglich Wechseln
-0.02 -1.16%
Monatlich
-3.39%
Jährlich
-14.07%
Q2 Prognose
1.69




Vermögenswerte Veränderung Datum
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Alaunos Therapeutics USD 2.97M 758K 2025-12
Avita Medical AUD 56.39M 1.74M 2025-12
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Genomma Lab Internacional MXN 24.8B 965.89M 2026-03
Hypermarcas BRL 25.16B 4.34M 2025-12
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
IQVIA Holdings USD 29.94B 1.22B 2025-12
Jiangsu Hengrui CNY 71.29B 1.43B 2026-03
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Moderna USD 12.34B 203M 2025-12
Organon & Co USD 12.87B 685M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Sh Fosun Pharma CNY 122.97B 2.91B 2026-03
Tectonic Therapeutic USD 261.04M 15.96M 2025-12
Viatris USD 37.19B 727.3M 2025-12
Wuxi Apptec CNY 103.12B 8.51B 2025-12
Xeris Pharmaceuticals USD 383.53M 13.34M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03